Dr Susan Catalano of Cognition Therapeutics talks the science behind the Icelandic Mutation and their potential upcoming drug for the treatment of Alzheimer disease.
How can we harness the technologies of today—and tomorrow—to expand access to mental health services?
45% to 75% of mental health professionals have personal experience with mental health care services, yet they may feel shame, embarrassment, and fear of being judged negatively for it.
Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?
Multidisciplinary insights on helping patients with ADHD during the COVID-19 pandemic, medication abuse, and other factors affecting care.
How can looking at the suffering of patients with schizophrenia through a psychodynamic lens help clinicians develop effective interventions and treatment plans?
Malingering is a common challenge for emergency department clinicians, particularly during the pandemic. Here are 3 cases of COVID-19–induced malingering.
Ann Childress, MD, the current president of APSARD, invites you to attend this year's conference!
Schizophrenia is one of the most recognized yet least understood chronic brain disorders.
We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?
A new poll sought to understand the public’s beliefs about mental health and suicide prevention. Here are the results.
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
How can clinicians distinguish between ordinary grief, depression, and prolonged grief disorder?
Exploring the association between methamphetamine use and the development of psychotic symptoms, such as paranoid delusions, ideas of reference, and auditory hallucinations.
How can we face the current pandemic while addressing the brain health crisis?
Here’s how you can effectively encourage treatment adherence when helping patients with substance use disorder.
How can clinicians recognize and acknowledge the injustices often experienced by COVID long-haulers?
Three women describe the massive impact COVID-19 has had on their lives.
An interview with Brendon Stubbs, PhD.
More than half of physicians believe that seeking psychiatric care would jeopardize their employment. What can be done?
A former resident's reflection on burnout, physician PTSD, and their consequences for patient care.
Richard K. Bogan, MD, FCCP, FAASM, and Asim Roy, MD, share take-home messages for the management of narcolepsy.
Beyond the COVID-19-driven shock, we must develop a resilient future in an increasingly uncertain world.
How can mindfulness-based intervention be used as an effective treatment option for psychiatric patients?
Safety planning by peers is feasible and acceptable to patients, might result in decreased ED visits, and may represent a way of implementing safety plans in rural EDs.
A new digital therapeutic helps patients with psychosis to slow down and manage their fears.
The pandemic has brought into focus treatment barriers, disruption in care, and possibly negative outcomes in the mental health of university students. To better understand the specific challenges of out-of-state students, the authors conducted an anonymous national survey of college psychiatrists.
Recent research investigated the benefits and risks of augmentation compared with switching strategies for TRD in older adults.
Beyond the COVID-19-driven shock, we must develop a resilient future in an increasingly uncertain world.